The immunosuppressive TGFβ cytokine isoforms contribute to immune evasion strategies promoted by tumors and in a number of cancers, TGFβ2 has been closely implicated in epithelial to mesenchymal transition (EMT), a precursor to the metastatic process (39). This evidence concerns the gene TGFB2 and cancer.